- Previous Close
0.2495 - Open
0.2545 - Bid 0.2425 x --
- Ask 0.2465 x --
- Day's Range
0.2360 - 0.2545 - 52 Week Range
0.1688 - 0.5990 - Volume
860,456 - Avg. Volume
3,510,687 - Market Cap (intraday)
262.212M - Beta (5Y Monthly) 1.48
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0900 - Earnings Date Feb 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.45
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.
www.acarix.comRecent News: ACARIX.ST
View MorePerformance Overview: ACARIX.ST
Trailing total returns as of 1/15/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ACARIX.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ACARIX.ST
View MoreValuation Measures
Market Cap
265.40M
Enterprise Value
221.22M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
35.62
Price/Book (mrq)
4.14
Enterprise Value/Revenue
38.97
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-80.41%
Return on Equity (ttm)
-155.11%
Revenue (ttm)
5.68M
Net Income Avi to Common (ttm)
-72.23M
Diluted EPS (ttm)
-0.0900
Balance Sheet and Cash Flow
Total Cash (mrq)
48.74M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-41.08M